http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-083706-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bb3a52fede77711d08747cbe80c826 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A45D37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 |
| filingDate | 2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24bb78ed2f45e885d08dd38c3e5f03e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b0f5cfa8790c59467c74977af690fb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c83e9645af21bbac1ffa5ffa49cd7fd |
| publicationDate | 2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-083706-A1 |
| titleOfInvention | A DEVICE FOR STORAGE AND ADMINISTER A TOPIC COMPOSITION OF OXIBUTININ NOT OCCUPIED |
| abstract | Claim 1: A device for storing and administering a topical composition of non-occluded oxybutynin comprising: a) a topical composition of non-occluded oxybutynin comprising: i) a therapeutically effective amount of oxybutynin; ii) a thickening agent and iii) 50% or more based on the weight of the topical composition of non-occluded oxybutynin of a solvent; b) a reservoir for the topical composition of non-occluded oxybutynin; and c) a laminate surrounding the reservoir and the topical composition of non-occluded oxybutynin comprising: i) a first polymer that is in contact with the topical composition of non-occluded oxybutynin; and ii) a metal sheet bonded to the first polymer layer in which the device can withstand 30 pounds (206.84 kPa) of pressure without bursting when pressed between two plates of a motorized test stand and when the device is stored at 25 ° C and 60% relative humidity for twenty six weeks; the topical composition of non-occluded oxybutynin contains no more than 0.2% ethyl ester of phenylcyclohexyl glycolic acid (PCCE); no more than 2.0% phenylcyclohexyl glycolic acid (PCCA) and there is no more than 20% change in solvent content. Claim 4: The device of claim 1 wherein the topical composition of non-occluded oxybutynin is a gel, cream or lotion. Claim 6: The device of claim 1 wherein the topical composition of non-occluded oxybutynin comprises about 2% to about 20% based on the total weight of the oxybutynin composition. Claim 21: A method for treating human patients suffering from overactive bladder comprising the steps of a) providing a storage and administration device as defined in claim 1 to a human being; b) dispensing a single or daily dose of the oxybutynin composition of the device; and c) applying the single or daily dose of the oxybutynin composition to a skin surface of the human patient. |
| priorityDate | 2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.